Metoprolol treatment of coronary heart disease and clinical observation and experience of chronic heart failure.docVIP

Metoprolol treatment of coronary heart disease and clinical observation and experience of chronic heart failure.doc

  1. 1、本文档共5页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Metoprolol treatment of coronary heart disease and clinical observation and experience of chronic heart failure

 PAGE \* MERGEFORMAT 5 Metoprolol treatment of coronary heart disease and clinical observation and experience of chronic heart failure [Abstract] Objective To observe metoprolol tartrate ( Inhibitor of coronary heart disease and chronic heart failure. Methods 60 patients with coronary heart disease in the general treatment based on the use of metoprolol tartrate was observed to improve cardiac function . Results of 30 cases significantly improved, 50%, improved in 18 cases, 30%, 80% total efficiency. Conclusion blockers can improve symptoms of coronary heart disease and prognosis of chronic heart failure and improve heart function is effective and security. [Keywords:] coronary heart disease with chronic heart failure Metoprolol Tartrate Coronary heart disease is one of the leading major cause of heart failure, the incidence increased significantly year by year. We used metoprolol tartrate therapy in patients with coronary heart disease and 60 patients with chronic heart failure, clinical efficacy, reported as follows: 1 Clinical data and methods 1.1 General information: The author collected from May 2006 to December 2009 were hospitalized heart failure patients with coronary heart disease and 60 patients, 38 males and 22 females, mean age of 70.2 years. New York Heart Association (NYHA points Level 2 cases of grade , grade 18 cases, LVEF was 40, have varying degrees of lower extremity edema. selected cases of bronchial asthma no more than atrioventricular block, hypotension, sinus disease, cardiogenic shock -blocker use and other contraindications. 1.2 Methods: metoprolol tartrate 6.25MG / time, 2 times / D, depending on patient condition and tolerance of 2 to 4 weeks for each dose was doubled, the target dose of 150 MG / D other treatment the same. Medication during the monitoring of blood pressure, fluid changes in retention and heart failure, bradycardia and atrioventricular block in order to adjust the dose. not to the target

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档